Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
Myriad Genetics, Inc. New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence SALT LAKE CITY,…